当前位置: X-MOL 学术Breast Cancer Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Breast Cancer Research ( IF 7.4 ) Pub Date : 2024-04-02 , DOI: 10.1186/s13058-024-01811-y
Muhammad Hasan Bashari , Fengjuan Fan , Sonia Vallet , Martin Sattler , Melissa Arn , Claudia Luckner-Minden , Henning Schulze-Bergkamen , Inka Zörnig , Frederik Marme , Andreas Schneeweiss , Michael H. Cardone , Joseph T. Opferman , Dirk Jäger , Klaus Podar

Correction: Breast Cancer Research (2016) 18:26 https://doi.org/10.1186/s13058-016-0686-4

Following the publication of the original article [1], the author reported that PARP blots of JIMT-1 and JIMT-1-BR3 cells in Fig. 7C of the original publication were mistakenly duplicated.

Error image

figure a

The correct figure below depicts the correct PARP blot for JIMT-1 cells.

Correct image

figure b

The error does not affect any of the interpretations or conclusions of the article.

The email address of the Corresponding Author has also been updated, from klaus.podar@nct-heidelberg.de to klaus.podar@krems.lknoe.at as shown in this Correction article.

The original article [1] has been updated.

  1. Bashari MH, Fan F, Vallet S, et al. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Breast Cancer Res. 2016;18:26. https://doi.org/10.1186/s13058-016-0686-4.

    Article CAS PubMed PubMed Central Google Scholar

Download references

Authors and Affiliations

  1. Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, 69120, Heidelberg, Germany

    Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Claudia Luckner-Minden, Henning Schulze-Bergkamen, Inka Zörnig, Frederik Marme, Andreas Schneeweiss, Dirk Jäger & Klaus Podar

  2. Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Jl. Eijkman 38, Bandung, 02215, Indonesia

    Muhammad Hasan Bashari

  3. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA

    Martin Sattler

  4. Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, USA

    Melissa Arn & Michael H. Cardone

  5. German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany

    Claudia Luckner-Minden, Inka Zörnig & Dirk Jäger

  6. St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA

    Joseph T. Opferman

Authors
  1. Muhammad Hasan BashariView author publications

    You can also search for this author in PubMed Google Scholar

  2. Fengjuan FanView author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonia ValletView author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin SattlerView author publications

    You can also search for this author in PubMed Google Scholar

  5. Melissa ArnView author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudia Luckner-MindenView author publications

    You can also search for this author in PubMed Google Scholar

  7. Henning Schulze-BergkamenView author publications

    You can also search for this author in PubMed Google Scholar

  8. Inka ZörnigView author publications

    You can also search for this author in PubMed Google Scholar

  9. Frederik MarmeView author publications

    You can also search for this author in PubMed Google Scholar

  10. Andreas SchneeweissView author publications

    You can also search for this author in PubMed Google Scholar

  11. Michael H. CardoneView author publications

    You can also search for this author in PubMed Google Scholar

  12. Joseph T. OpfermanView author publications

    You can also search for this author in PubMed Google Scholar

  13. Dirk JägerView author publications

    You can also search for this author in PubMed Google Scholar

  14. Klaus PodarView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Podar.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bashari, M.H., Fan, F., Vallet, S. et al. Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Breast Cancer Res 26, 58 (2024). https://doi.org/10.1186/s13058-024-01811-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13058-024-01811-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative



中文翻译:

更正:Mcl-1 赋予 Her2 阳性乳腺癌细胞缺氧保护:治疗意义

更正:乳腺癌研究(2016)18:26 https://doi.org/10.1186/s13058-016-0686-4

原文章发表后 [1],作者报告说,原文章图 7C 中的 JIMT-1 和 JIMT-1-BR3 细胞的 PARP 印迹被错误地重复。

错误图像

图一

下图正确描绘了 JIMT-1 细胞的正确 PARP 印迹。

正确的图像

图b

该错误不影响文章的任何解释或结论。

通讯作者的电子邮件地址也已更新,从 klaus.podar@nct-heidelberg.de 更改为 klaus.podar@krems.lknoe.at,如本更正文章中所示。

原文章[1]已更新。

  1. Bashari MH、Fan F、Vallet S 等。 Mcl-1 赋予 Her2 阳性乳腺癌细胞缺氧保护:治疗意义。乳腺癌研究中心。 2016;18:26。 https://doi.org/10.1186/s13058-016-0686-4。

    文章 CAS PubMed PubMed Central Google Scholar

下载参考资料

作者和单位

  1. 海德堡大学国家肿瘤疾病中心 (NCT) 肿瘤内科,Im Neuenheimer Feld #460, 69120,海德堡,德国

    Muhammad Hasan Bashari、Fengjuan Fan、Sonia Vallet、Claudia Luckner-Minden、Henning Schulze-Bergkamen、Inka Zörnig、Frederik Marme、Andreas Schneeweiss、Dirk Jäger 和 Klaus Podar

  2. 巴贾查兰大学医学院药理学和治疗系Eijkman 38, 万隆, 02215, 印度尼西亚

    穆罕默德·哈桑·巴沙里

  3. 达纳法伯癌症研究所,450 Brookline Avenue,波士顿,MA,02215,美国

    马丁·萨特勒

  4. Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, 美国

    梅丽莎·阿恩 & 迈克尔·H·卡登

  5. 德国癌症研究中心 (DKFZ),Im Neuenheimer Feld 460, 69120,海德堡,德国

    克劳迪娅·卢克纳-明登、Inka Zörnig 和 Dirk Jäger

  6. 圣裘德儿童研究医院,262 Danny Thomas Place,孟菲斯,田纳西州,38105,美国

    约瑟夫·T·奥普弗曼

作者
  1. 穆罕默德·哈桑·巴沙里查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  2. 范凤娟查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  3. Sonia Vallet查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  4. 马丁·萨特勒查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  5. 梅丽莎·阿恩查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  6. 克劳迪娅·卢克纳-明登查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  7. Henning Schulze-Bergkamen查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  8. Inka Zörnig查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  9. Frederik Marme查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  10. Andreas Schneeweiss查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  11. Michael H. Cardone查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  12. 约瑟夫·T·奥普弗曼查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  13. Dirk Jäger查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  14. 克劳斯·波达尔查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

通讯作者

克劳斯·波达尔的通讯。

出版商备注

施普林格·自然对于已出版的地图和机构隶属关系中的管辖权主张保持中立。

开放获取本文根据知识共享署名 4.0 国际许可证获得许可,该许可证允许以任何媒介或格式使用、共享、改编、分发和复制,只要您对原作者和来源给予适当的认可,提供知识共享许可的链接,并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非材料的出处中另有说明。如果文章的知识共享许可中未包含材料,并且您的预期用途不受法律法规允许或超出了允许的用途,则您需要直接获得版权所有者的许可。要查看此许可证的副本,请访问 http://creativecommons.org/licenses/by/4.0/。知识共享公共领域奉献豁免 (http://creativecommons.org/publicdomain/zero/1.0/) 适用于本文中提供的数据,除非数据的信用额度中另有说明。

转载和许可

检查更新。通过 CrossMark 验证货币和真实性

引用这篇文章

Bashari, MH、Fan, F.、Vallet, S.等人。更正:Mcl-1 赋予 Her2 阳性乳腺癌细胞缺氧保护:治疗意义。乳腺癌研究 26 , 58 (2024)。 https://doi.org/10.1186/s13058-024-01811-y

下载引文

  • 发表

  • DOI https://doi.org/10.1186/s13058-024-01811-y

分享此文章

您与之分享以下链接的任何人都可以阅读此内容:

抱歉,本文目前没有可共享的链接。

由 Springer Nature SharedIt 内容共享计划提供

更新日期:2024-04-02
down
wechat
bug